Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Identity, Access Management & Biometric Solutions Provider BIO-key International Hosts Q4 Investor Call Thursday, March 27th at 10am ET
-
STRATA Skin Sciences Highlights New Clinical Study from Japan Demonstrating Superiority of Narrow Band Excimer Laser Over Non Narrow Band UVB-Source Like Excimer Light
-
Malbek Promotes Colin Levy to General Counsel
-
Driven Brands Holdings Inc. (Nasdaq: DRVN) Securities Fraud Class Action Survives Motion to Dismiss. Grabar Law Investigates Claims for Long-Term Shareholders
-
USDA Informs NAPIGEN, Inc. Its CMS Rice Is Not Subject to Regulation
-
Richtech Robotics and Ghost Kitchens Announce Restaurant Opening at Peachtree City Walmart
-
NeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in Revenues
-
Trust Wallet Tops Crypto Wallet Downloads for March 2025
-
CorVista Health to Present New Data on Non-Invasive Point of Care Test for Pulmonary Capillary Wedge Pressure Elevation Using Machine Learning at ACC.25
-
Microchip Technology Engages Macquarie Group to Facilitate Sale of Tempe Fab 2 Wafer Fabrication Facility
-
InFlux Technologies Teams Up with NexGen Cloud to Deliver Hyperstack Solutions Built with NVIDIA AI Accelerated Computing Platform
-
PBGH Advisory Services Available Nationwide to Provide Fiduciary Support to Employers Sponsoring Health Benefits
-
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
-
Invivyd Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Recent Business Highlights
-
CIRRO Fulfillment expands European presence with new fulfillment centers in Spain and Italy
-
Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell’s Phase 3 Study in Metastatic Breast Cancer
-
BriteCore Named “Best P&C InsurTech Solution” in 9th Annual FinTech Breakthrough Awards Program
-
Cerence AI Adds Former Ford Executive Marion Harris to its Board of Directors
-
Axonius Unveils Unified Identity Management & Security Solution to Centralize IAM Program Operations
-
Global Uranium and Forum Energy Metals Announce the Commencement of Drilling and Ground Geophysical Surveys on the Northwest Athabasca Project, Saskatchewan
-
Acesis BioMed Launches Crowdfunding Campaign to Develop a Novel Treatment for low Testosterone in Men
-
Windtree Announces License and Supply Agreement to Become Sourcing Partner for a Small Biotech with an FDA Approved Product
-
Corvus Pharmaceuticals Announces Presentation of Additional Data from the Phase 1/1b Clinical Trial of Soquelitinib for Patients with T Cell Lymphoma
-
Steve Madden Partners with RunDTC & Contentstack for eCommerce Transformation on Shopify
-
VYNE Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference
-
Young Bettors and March Madness Participants Face High Gambling Risks
-
BioAtla Announces Two Poster Presentations at Upcoming Medical Meetings
-
Beyond Identity and Nametag Announce Strategic Partnership to Strengthen Identity & Access Management Using Deepfake Defense™ Identity Verification
-
PubMatic’s Connect Platform for Curation Delivers for Publishers: Drives 25%+ Higher eCPMs, Incremental Revenue and Diverse Demand
-
First Responders Children's Foundation Announces Chief Theresa Tobin as Chief National Public Safety Liaison
-
Reflect Scientific Inc. Reports Strong Revenue Growth in 2024
-
Milestone Pharmaceuticals to Present Clinical Data on Etripamil at the American College of Cardiology
-
LiveOne (NASDAQ: LVO) Exceeds 1.3M Subscribers and Ad-Supported Users, Including Tesla
-
Pathos AI Doses First Patient in Phase 1b/2a Clinical Trial of Pocenbrodib, a CBP/p300 Inhibitor
-
Founder Group Secures Contract Valued at US$2.6 Million to Build a Roof-Top Solar Generating Facility in Malaysia
-
Indaptus Therapeutics Reports New Data Demonstrating Successful Broad Immune System Activation in Weekly Dosing Trial of Decoy20
-
Academy Sports + Outdoors Reports Fourth Quarter and Fiscal 2024 Results
-
REPEAT: Rocket Doctor Scales Rapidly in Alberta, Strengthening Physician Independence and Expanding Healthcare Access
-
Candel Therapeutics and IDEA Pharma Announce Strategic Partnership to Advance Path-to-Market Commercialization Efforts for CAN-2409
-
Immutep to Present Pivotal TACTI-004 Trial in Progress Poster at the European Lung Cancer Congress 2025
-
KICK Announces KICK Partner Fast Track Program with OTK Subsidiary Cross Realm Inc.
-
BriteCore Named “Best P&C InsurTech Solution” in 9th Annual FinTech Breakthrough Awards Program
-
NevGold Increases the Size of the Zeus Copper Project by Approximately 50% Or 1,000 Hectares in the Hercules Copper District, Idaho
-
Steve Madden Partners with RunDTC & Contentstack for eCommerce Transformation on Shopify
-
Teledyne’s new 2.5 GigE Vision line scan camera delivers industry-leading performance in a cost-effective package
-
Medera Receives DSMB Clearance to Initiate Phase 2 Portion of MUSIC-HFrEF Phase 1b/2 Trial for SRD-001 Gene Therapy in Heart Failure with Reduced Ejection Fraction
-
Nitrase Therapeutics Unveils Protein with Newly Characterized Enzymatic Function Involved in the Pathogenesis of Parkinson’s Disease
-
Axonius Unveils Unified Identity Management & Security Solution to Centralize IAM Program Operations
-
Esperion Aligns with U.S. Food and Drug Administration to Initiate Phase 3 Clinical Trials of Bempedoic Acid in Pediatric Heterozygous and Homozygous Familial Hypercholesterolemia
-
Yara refinances revolving credit facility with 11 banks
